T-lymphocyte interleukin 2-dependent tyrosine protein kinase signal transduction involves the activation of p56lck.

Ivan D. Horak(National Cancer Institute), Ronald E. Gress(National Cancer Institute), Philip J. Lucas(National Cancer Institute), Eva Horak(National Cancer Institute), T. A. Waldmann(National Cancer Institute), Joseph B. Bolen(National Cancer Institute)
Proceedings of the National Academy of Sciences
March 1, 1991
Cited by 212Open Access

Abstract

Addition of interleukin 2 (IL-2) to IL-2-dependent T cells results in tyrosine protein kinase signal transduction events even though the IL-2 receptor alpha and beta chains lack intrinsic enzymatic activity. Here we report that addition of IL-2 to IL-2-dependent human T cells transiently stimulates the specific activity of p56lck, a member of the src family of nonreceptor tyrosine protein kinases expressed at high levels in T lymphocytes. The ability of IL-2 to induce p56lck activation was found to be independent of the capacity of p56lck to associate with either CD4 or CD8. Following IL-2 treatment, p56lck was found to undergo serine/threonine phosphorylation modifications that resulted in altered mobility of the lck gene product on polyacrylamide gels. These observations raise the possibility that p56lck participates in IL-2-mediated signal transduction events in T cells.


Related Papers

No related papers found

Powered by citation graph analysis